HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Bishop Selected Research

Ewing Sarcoma (Sarcoma, Ewing)

1/2022Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Bishop Research Topics

Disease

4Neoplasms (Cancer)
01/2023 - 08/2010
4Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 08/2010
3Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 01/2017
2Sarcoma (Soft Tissue Sarcoma)
01/2022 - 01/2017
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2020 - 09/2012
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 08/2010
2Infections
02/2007 - 12/2006
1Cytokine Release Syndrome
01/2024
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2024
1cell-associated neurotoxicity
01/2024
1Ewing Sarcoma (Sarcoma, Ewing)
01/2022
1Heart Failure
01/2022
1Atherosclerosis
01/2022
1Acute Coronary Syndrome
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2020
1Residual Neoplasm
01/2019
1Spontaneous Fractures (Pathological Fracture)
01/2017
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2016
1Prostatic Neoplasms (Prostate Cancer)
03/2012
1Fatigue
04/2011
1Chronic Disease (Chronic Diseases)
04/2011
1Leukemia
08/2010
1Hypotension (Low Blood Pressure)
10/2009
1Vulvar Diseases
11/2007
1Bronchiolitis Obliterans Syndrome
11/2007
1Cicatrix (Scar)
11/2007
1Virus Diseases (Viral Diseases)
02/2007
1Parkinson Disease (Parkinson's Disease)
05/2006
1Tumor Lysis Syndrome
10/2004
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2002

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2012
2AntigensIBA
03/2012 - 02/2007
1Chimeric Antigen ReceptorsIBA
01/2024
1axicabtagene ciloleucelIBA
01/2024
1tisagenlecleucelIBA
01/2024
1ORALIT (ORS)IBA
01/2024
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023
1Proteins (Proteins, Gene)FDA Link
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1selinexorIBA
11/2020
1NivolumabIBA
01/2020
1VaccinesIBA
08/2010
1Estrogens (Estrogen)FDA Link
11/2007
1GlucocorticoidsIBA
11/2007
1Viral DNAIBA
02/2007
1RNA (Ribonucleic Acid)IBA
02/2007
1DNA (Deoxyribonucleic Acid)IBA
02/2007
1Viral RNAIBA
12/2006
1NestinIBA
05/2006
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
05/2006

Therapy/Procedure

6Therapeutics
01/2024 - 10/2004
4Hematopoietic Stem Cell Transplantation
11/2020 - 11/2007
3Transplantation
01/2023 - 01/2002
2Cell Transplantation
10/2021 - 08/2010
2Surgical Amputation (Amputations)
01/2017 - 01/2017
1Stem Cell Transplantation
01/2020
1Contraindications
01/2017
1Neoadjuvant Therapy
01/2017
1Limb Salvage
01/2017
1Rehabilitation
01/2017
1Chemoradiotherapy
01/2016
1Immunotherapy
08/2010
1Anesthesia
10/2009